Furthermore, in a proof-of-concept study, eight surface proteins (EpCAM, CD44, HER2, EGFR, IGFR, CD81, CD63, CD9) on model exosomes derived from breast cancer cells were analyzed. This evidence concerns the gene ERBB2 and breast cancer.